Stock Groups

U.S. has more than 36,000 doses of Jynneos vaccine available in stockpile


According to the Health and Human Services Department of the United States, there are more than 36,000 Jynneos Monkeypox vaccinations in their strategic national stockpile.

In an attempt to prevent the disease spreading, the Centers for Disease Control and Prevention will send the vaccine to those who are at high risk of being exposed to it. Up to Friday, there were 25 monkeypox confirmed cases in the United States.

According to the U.S. Bavarian NordicAn HHS spokesperson stated that Jynneos will be shipped to a Danish-based biotech company called. Bavarian Nordic has more than 1,000,000 doses of Jynneos and is able to fill 16.4 Million more upon request from the U.S., according to the spokesperson.

Monkeypox is now the most widespread pandemic outside of Africa. Nearly 800 cases have been confirmed in monkeypox, and they are spread across 27 countries. The majority of cases have been reported to the World Health Organization in Europe, especially in Spain, Portugal and the United Kingdom.

Jynneos was approved by the Food and Drug Administration for adult patients 18 and over at risk of developing smallpox. Two-dose vaccinations are the only approved shot to prevent monkeypox. The spokesperson stated that the U.S. has over 100 million doses ACAM2000 of an older smallpox vaccine. ACAM2000 is manufactured by Emergent BioSolutions

According to Dr. Raj Panjabi who heads the White House Pandemic Preparedness Office, 1,200 Jynneos or ACAM2000 were given out by the U.S., for individuals at highest risk from monkeypox. He spoke with reporters Friday.

ACAM2000, which was developed to prevent smallpox and other diseases in 2007, was approved by FDA. However, ACAM2000 can be administered to monkeypox patients under a CDC program. Although it’s milder than smallpox and is part of the same virus family, monkeypox can also be found.

Panjabi stated that the U.S. also distributes tecovirimat, an oral antiviral. It can be used for treating monkeypox patients. Tecovirimat, which was approved in 2018 by FDA to treat smallpox and can be used under a CDC program for monkeypox.

Jynneos is generally recommended by the CDC over ACAM2000. ACAM2000 can cause serious side effects. ACAM2000 is a mild, live virus that has the potential to spread throughout the body. A single dose is used to administer the vaccine. It is injected into one arm and then the virus forms a localized infection as a blister.

If the patient scratches the blister, then rubs the eye to spread the virus, it can cause vision damage. It can spread to the family members, including those who are pregnant or nursing. FDA advises people receiving ACAM2000 to ensure that the site is properly cleaned so the virus doesn’t spread.

ACAM2000 is not recommended for everyone. This is due to side effects. People with severe skin conditions, heart disease, and pregnant women are all eligible to receive ACAM2000.

Pregnant women could be infected by the vaccine and have stillbirths. The virus can spread rapidly and cause serious infections in people with weak immune systems. People with skin conditions like eczema and atopic dermatology are at greater risk for the virus to spread on their skin, causing serious infections. ACAM2000 can also cause heart inflammation (myocarditis or pericarditis).

Side effects of the Jynneos vaccine are very rare because it uses a milder strain of virus which is not capable to reproduce in the body.

ACAM2000, which has shown high protection against monkeypox virus in animal models, is predicted to offer 85% protection from disease, as opposed to older smallpox vaccines. According to Mark Slifka, an immunologist at Oregon Health and Science University, ACAM2000 will provide similar protection to other versions. Slifka says that although not as much is known regarding the effectiveness of Jynneos, the vaccine produced strong antibodies in humans, and this should help protect against serious illness.

Officials in public health have expressed concern about the worldwide monkeypox crisis. The virus is rarely found outside West Africa and Central Africa. The virus is known to have spread from animals such as rodents, to humans living in isolated villages across Africa. According to Slifka, however, it appears that the virus is now more easily transmitted between individuals through physical contact.

WHO officials stated that last week, the virus was likely to have been infected outside of Africa. It is not known how long.

The WHO states that most of these cases were reported by gay or bisexual men, who have developed their own systems and sought out treatment in sexual health clinics. Officials from the WHO have stressed that monkeypox can be contracted by anyone who has close contact with them. But, health officials stressed the importance of raising awareness about the condition in the LGBTQ community to ensure that people can take precautions and protect their own health.

A CDC official Dr. Jennifer McQuiston told reporters that the majority of U.S. victims had a history that included international travel within the last 21 days. This suggests that the patient may have contracted the virus from abroad. McQuiston indicated that while the CDC isn’t confirming monkeypox spreading in the United States, there is still the possibility of it being transmitted to domestic patients.

Monkeypox is usually treated with non-invasive medical treatments within two to four weeks. However, the painful rashes associated with the disease can make it difficult for some people to recover. According to McQuiston, the current health danger for the public is minimal.

Monkeypox typically starts as symptoms of the flu, and then spreads to other parts of the body. This virus can be transmitted from skin to skin contact. Monkeypox can be transmitted to others through sharing sheets or clothes. The virus can be spread by people with lesions in the throat and mouth, but it is not difficult to transmit the virus via respiratory droplets.

The CDC advises that people suffering from confirmed or suspected monkeypox infection should stay at home, until the state or local health department makes an exception. Monkeypox patients should be kept in isolation until the rashes are gone, have fallen off, or a new layer has been formed.